I

Incyte

Biopharmaceutical company pursuing drug discovery.

Investigative Safety Scientist/Toxicologist

Translational Research & Bench BiologyPosted on Nov 10
Full-timeWilmington, DE, USANo salary listedIn-person

About the Job

Requirements

  • A Ph.D. in Toxicology, Pharmacology, Cell Biology, or a related discipline, with 6–10 years of relevant biotechnology or pharmaceutical experience.
  • Strong expertise in investigative and mechanistic toxicology and approaches to characterize drug-induced safety liabilities.
  • Experience with advanced in vitro models and assay development, including 3D cultures, organoids, co-cultures, organ-on-a-chip systems, and relevant cellular and molecular techniques.
  • Familiarity with omics and computational approaches applied to mechanistic toxicology.
  • Demonstrated success working within cross-functional drug discovery and development teams.
  • Agility to work across different modalities and organ systems.
  • Scientific judgment, critical thinking, and problem-solving skills, with the ability to translate complex findings into actionable recommendations.
  • Communication, collaboration, and organizational skills.

Responsibilities

  • Develop and execute investigative toxicology strategies to elucidate mechanisms of toxicity and address potential safety liabilities.
  • Design and apply fit-for-purpose in vitro and ex vivo models and new approach methodologies, including advanced 2D and 3D cultures, organoids, co-cultures, and organ-on-a-chip systems.
  • Evaluate and implement emerging technologies, automation, and high-throughput approaches to improve toxicity prediction and translational safety assessment; collaborate with internal and external partners to drive technological innovation.
  • Design and oversee in vivo investigative studies and integrate mechanistic, computational, and multi-omics data to identify safety liabilities, biomarkers, and translational relationships.
  • Collaborate with nonclinical safety scientists and cross-functional teams to translate scientific findings into actionable safety strategies and portfolio decisions.
  • Advise on appropriate model selection, risk characterization, and follow-up strategies, and provide recommendations to inform candidate progression.
  • Provide support and strategic leadership for the safe development of diverse modalities across multiple organ systems.
  • As needed, serve as a discovery-facing project toxicologist, providing nonclinical safety strategies to support drug discovery and candidate progression through candidate nomination; regulatory-phase project toxicology responsibilities may be considered based on the candidate’s experience and preferences.

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs